Qualifacts, a major behavioral health Electronic Health Record (EHR) provider, has acquired MethodOne by Computalogic to add controlled-medication dispensing capabilities to its platform. Financial terms were not disclosed. MethodOne provides comprehensive controlled-medication dispensing software purpose-built for Opioid Treatment Programs (OTPs) and Substance Use Disorder (SUD) providers.
Treatment agencies are actively shifting away from standard office-based opioid treatment (OBOT) models and transitioning into full-fledged Opioid Treatment Programs (OTPs), which collectively treat over half a billion patients annually, heavily skewing toward Medicaid. The shift is driven by simpler and more structured billing workflows for OTPs. However, taking advantage of those OTP billing structures requires software that can flawlessly track medication inventory, verify dispensing limits, and link those actions directly to a billable clinical encounter.
According to Qualifacts’ CEO Josh Schoeller, “Large SUD and mental health organizations require an integrated MAT [Medication-Assisted Treatment] and MOUD [Medications for Opioid Use Disorder] solution to operate effectively, and until now, that has meant cobbling together multiple systems.” He added that “bringing MethodOne into the Qualifacts family means our customers get a more complete behavioral healthcare EHR platform.”
OTPs operate under extreme regulatory scrutiny from overlapping agencies, including the DEA, SAMHSA, and state regulators. Behavioral health providers cannot afford to waste time managing clunky API bridges between mismatched vendors. The acquisition signals that the era of the fragmented addiction treatment tech stack is coming to an end, giving way to unified platforms that protect both the patient and the provider’s license.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://hitconsultant.net/2026/04/07/qualifacts-acquires-methodone/